TGFB2 and pancreatic neoplasm: Trabedersen (AP 12009) was one kind of ASO modified by phosphorothioate linkages, which targeted human TGF-β2 mRNA and was capable of reducing TGF-β2 secretion in Hup-T3 and PA-TU-8902 pancreatic cancer cells.